Skip to main content

Table 2 Summary of Immunohistochemistry results for E2F5 antibody tested on OEC

From: E2F5 status significantly improves malignancy diagnosis of epithelial ovarian cancer

Type of tissue Number of cases Number positive Percentage positive
Fimbrial/Paratubal/Paraovarian cyst 6 0 0
Surface epithelium/inclusion cysts 14 0 0
Endometriotic cyst 4 0 0
Serous cystadenoma 8 0 0
Mucinous cystadenoma 5 0 0
Benign stromal tumour 4 0 0
Dermoid tumour (mature) 12 0 0
Total 67 0 0
Early and late malignant cases    
Serous borderline and malignant E6; L8 24 (4+20) 11(2+9) 45.8
Mucinous borderline and malignant E11; L1 13 (6+7) 4(1+3) 30.77
Endometroid borderline and malignant E7; L5 16 (2+14) 8(1+7) 50
Clear cell carcinoma E2; L1 4 0 0
Adenocarcinoma (not further specified) E2; L2 4 2 50
Mixed adenocarcinoma E3; L1 7 6 85.7
Total 68 31 45.6
  1. Note: Stage I/II (E); Stage III/IV (L) and data not available 5